This compound belongs to the class of organic compounds known as 6-aminopurines. These are purines that carry an amino group at position 6. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring.
External Descriptors
Not available
1. Djoumbou Feunang Y, Eisner R, Knox C, Chepelev L, Hastings J, Owen G, Fahy E, Steinbeck C, Subramanian S, Bolton E, Greiner R, and Wishart DS. ClassyFire: Automated Chemical Classification With A Comprehensive, Computable Taxonomy. Journal of Cheminformatics, 2016, 8:61.
Soluble in 0.1N NaOH. Hardly soluble in hot water, DMSO. Insoluble in alcohol, ether, chloroform.
Siedepunkt (°C)
~497.5° C at 760 mmHg (Predicted)
Schmelzpunkt (°C)
>250° C
Molekulargewicht
214.020 g/mol
XLogP3
0.800
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
0
Exact Mass
212.965 Da
Monoisotopic Mass
212.965 Da
Topological Polar Surface Area
80.500 Ų
Heavy Atom Count
11
Formal Charge
0
Complexity
154.000
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
The total count of all stereochemical bonds
0
Covalently-Bonded Unit Count
1
Lösungsrechner
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Bewertungen
Kundenbewertungen
Application Protocols
No standardized biological assay protocols are claimed for this item. Usage is application-dependent (synthetic chemistry, nucleoside assembly, or in vitro biophysical assays).
General preparation examples (research use; adapt to your system)
Stock solution for screening: Dissolve to 100 mM in anhydrous DMSO; vortex and sonicate gently if needed. Filter (0.22 µm PTFE) for particulate removal. Store aliquots at 2–8 °C or frozen; minimize freeze–thaw.
Aqueous working solutions: Dilute DMSO stock into buffer (e.g., 10 mM Tris, pH 8.0) to a final DMSO content ≤1–2% v/v to maintain solubility. Prepare fresh.
Cross-coupling setup: Charge flame-dried vial with 8-bromoadenine, aryl boronic acid (1.2–1.5 equiv), base (3 equiv), Pd catalyst (1–2 mol%), and DMF/H2O (10:1). Heat 80–90 °C under N2 until TLC/LC-MS indicates completion; work up by dilution, filtration through celite, and crystallization or chromatography.
Assay notes
Verify compound integrity by LC-MS/NMR prior to sensitive measurements.
Avoid prolonged exposure to strong base or high temperature in aqueous media to limit degradation.
For detailed, validated protocols, consult primary literature aligned with your transformation or assay.
Biological Roles
Context: This section provides general, literature-based background on adenine analogs in biochemical research; it does not imply any clinical or diagnostic use.
Structural analog of adenine
8-Bromination perturbs the electronic distribution of the purine ring and can influence base stacking and hydrogen-bonding patterns in nucleic acid contexts (in vitro models).
Such modifications are useful for probing enzyme–substrate recognition, nucleotide binding pockets, and nucleic acid conformational preferences.
Enzymology and binding studies (in vitro)
8-substituted adenines and their nucleosides/nucleotides are commonly employed to map active sites of adenine-binding enzymes (e.g., kinases, polymerases, deaminases) by modulating steric/electronic features at the 8-position.
Photophysical and spectroscopic probes: Changes in UV absorbance and fluorescence quenching can be leveraged to track interactions in nucleic acid–protein assemblies.
Nucleoside/nucleotide derivatization
8-bromoadenine serves as a precursor to 8-substituted adenosines/AMPs used in structural biology (e.g., crystallography co-crystals) and biophysical assays (e.g., melting curves), where C8 modification provides controlled perturbations.
Important caveats
Biological activity depends strongly on the exact derivative (nucleoside/nucleotide, protecting groups, substituent), concentration, and system studied.
No claims are made regarding therapeutic or diagnostic performance. Use strictly for research in appropriate containment following institutional guidelines.
Buffer Applications
This compound is not a buffering agent and is not typically used to prepare buffer systems.
Practical notes for solution prep in buffered media (research use)
Prepare a concentrated stock in DMSO (e.g., 10–100 mM, as solubility permits) and dilute into the working buffer with vigorous mixing.
Alternatively, dissolve directly in mildly basic buffers (pH 8–9; e.g., Tris, borate, carbonate) with gentle warming to aid solubility.
Filter-sterilize solutions if required for sensitive assays; avoid prolonged storage in aqueous solution to minimize hydrolysis/degradation.
For pH-stable systems, select buffers appropriate to your downstream assay; the compound itself does not impart buffering capacity.
Green Alternatives
Greener practice focuses on solvent and catalyst choices, since the substrate itself (a brominated heteroaromatic) is fixed.
Solvent substitutions (literature-guided)
Replace DMF/DMAc/NMP with more benign media where feasible: 2-methyltetrahydrofuran (2-MeTHF), cyclopentyl methyl ether (CPME), propylene carbonate (PC), or water/ethanol systems with phase transfer.
For Suzuki couplings, consider ethanol/water or 2-MeTHF with aqueous base; many boronic acids perform well in mixed green solvents.
For SNAr, sulfolane or PC can sometimes substitute for DMSO/DMF while maintaining polarity.
Catalysis and conditions
Employ ligand-efficient Pd systems at low loading (≤1 mol%) or explore Ni-catalyzed couplings with air-stable precatalysts.
Microwave or flow chemistry can shorten reaction times, lowering energy input.
Workup and purification
Favor aqueous crystallization or minimal solvent trituration over silica chromatography when possible.
Use greener eluents (ethyl acetate/hexanes replaced by EtOAc/cyclohexane or EtOAc/MeOH) and recycle solvents.
Comparison (general; illustrative)
Conventional: DMF, Pd(PPh3)4 (2–5 mol%), 80–100 °C, column chromatography.
Greener: 2-MeTHF or EtOH/H2O, Pd/C or modern phosphine ligands (≤1 mol%), 60–80 °C, crystallization-based isolation.
Trade-offs
Solubility of purines may limit use of hydrophobic solvents; co-solvent strategies or mild base adjustments can help.
Catalyst activity/selectivity may require optimization when changing solvent or metal.
Pharmaceutical Uses
No pharmacopeial/excipient status or formulation role is specified for this item; refer to CoA/Spec Sheet.
General, non-clinical context (literature)
As a functionalized purine, 8-bromoadenine is primarily a synthetic intermediate for generating 8-substituted adenine nucleosides/nucleotides that may be evaluated in discovery research.
In medicinal chemistry workflows, the C8–Br handle enables rapid diversification (C–C, C–N, C–O, C–S) on adenine scaffolds for SAR exploration in enzyme or receptor-binding studies.
Solid handling: high-melting, non-hygroscopic behavior is typical; facilitates weighing and storage.
Solution handling: DMSO or DMF concentrates can be prepared for assay addition; ensure compatibility with formulation excipients and avoid high pH where base-promoted degradation could occur over time.
Impurity control: Monitor for dehalogenated adenine and residual metal from cross-coupling sequences if material is used downstream in research-scale preparations.
Compliance and use restrictions
For research use only. Not for use in humans or diagnostic procedures. No medical claims are made for this product.
Physical Properties
Item-specific data
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
Literature/computed (for reference; not item-specific specifications)
Empirical formula (literature): C5H4BrN5
Formula weight (literature): ~214.02 g/mol
Physical state: High-melting, crystalline solid; reported to decompose on strong heating (literature, typical for halogenated purines).
Solubility (qualitative, literature):
Water: low at neutral pH; improved in hot water or with pH adjustment (acidic or basic).
Polar aprotic solvents: soluble/sparingly soluble in DMSO and DMF; limited in acetonitrile and alcohols.
Aqueous buffers: better solubility in mildly basic buffers (e.g., pH 8–9) or with cosolvent (DMSO 5–20%).
Acid–base behavior (literature): Adenine derivatives possess multiple basic nitrogens; apparent pKa values for ring nitrogens typically in the range pKa1 ~1–2 (protonation) and pKa2 ~9–10 (exocyclic amine), but exact values depend on substitution; 8-bromo decreases basicity at C8-adjacent sites.
UV absorbance (qualitative): Purine chromophore absorbs in the UV (≈260 nm region, literature); specific cutoff/ε not established for this item.
Note: For authoritative, lot-specific values (mp, water content, UV cutoff, metals), consult the CoA/Spec Sheet.
Quality and Grades
Item-specific grade/purity: Not specified for this item; refer to CoA/Spec Sheet.
How to interpret grades (general guidance)
Research grade: Suitable for most synthetic and biochemical research applications. Typical controls include identity (NMR/HRMS), purity (HPLC/GC/LC-MS), and appearance.
Assay/purity reporting: For heteroaromatic solids, HPLC area % or qNMR is commonly used. Residual solvent, water content (Karl Fischer), and inorganic residue (sulfated ash) may be included in the CoA.
Low-metal/trace specifications: Relevant when using Pd-catalyzed couplings on this substrate and later requiring ultralow metal residues; if critical, request trace metals data or select a grade designed for catalytic sequence use.
Stabilizers and additives
Stabilizer: Not typically required for purine solids; none specified for this item.
Impurities of note (general): Dehalogenated adenine, oxidative dimers, and inorganic halide are typical process-related impurities; chromatography or crystallization affords high purity.
What to verify for your application
Nucleoside synthesis: Ensure low water content and high assay purity for efficient glycosylation.
Cross-coupling: Confirm minimal halogen-deficient impurities; evaluate by LC-MS for dehalogenated species.
Bioassays and photophysics: If UV background is critical, request a UV–Vis scan or HPLC with diode-array detection.
Always defer to the lot-specific CoA/Spec Sheet for definitive specifications.
Reaction and Applications
This substrate is widely used as a functionalized purine for derivatization at the C8 position and for nucleoside assembly.
C8 cross-coupling (literature)
Suzuki–Miyaura: 8-bromoadenine couples with aryl/heteroaryl boronic acids to furnish 8-aryl adenines using Pd(0) catalysts (e.g., Pd(PPh3)4) and carbonate bases in DMF/DMAc or dioxane/H2O at 60–110 °C.
Sonogashira: Access 8-alkynyl adenines using Pd/Cu co-catalysis, terminal alkynes, and amine base (Et3N, DIPEA) in DMF or acetonitrile.
Buchwald–Hartwig-type amination: Formation of 8-arylamino derivatives with suitable ligands and bases under Pd catalysis.
Nucleophilic aromatic substitution (SNAr)
The C8–Br can be displaced by amines, thiols, or alkoxides under basic conditions (often with heat) to yield 8-amino-, 8-thio-, or 8-alkoxyadenines. Cu(I) catalysis (Ullmann-type) can accelerate C–N/O/S bond formation with aryl/heteroaryl nucleophiles.
N9 glycosylation to nucleosides
After base silylation (e.g., HMDS/TMSCl), Vorbrüggen glycosylation with activated sugars (peracetylated glycosyl donors, TMSOTf) provides 8-bromoadenosines, which are versatile intermediates for further C8 diversification on the nucleoside.
Research utility (non-clinical)
Commonly employed as a chemical probe precursor for preparing 8-substituted adenine derivatives to study nucleic acid structure, enzyme active-site recognition, or ligand–nucleobase interactions in vitro.
Practical tips
Dry, oxygen-free conditions improve Pd-catalyzed cross-couplings; include water only when required for base solubility.
Monitor for dehalogenation (adenine formation) as a side reaction; adjust catalyst/ligand and reduce temperature to suppress.
Protect exocyclic –NH2 when chemoselectivity is a concern (e.g., acyl or silyl protection) to direct reactivity to C8.
Reaction Conditions
The following are typical, literature-referenced conditions for 8-bromoadenine; they are general guidelines and not product specifications.
Suzuki–Miyaura coupling (to 8-aryl adenines)
Catalyst: Pd(PPh3)4 (1–3 mol%) or Pd2(dba)3/XPhos-type ligands.
Base: K2CO3 or Cs2CO3 (2–3 equiv).
Solvent: DMF, DMAc, or 1,4-dioxane/H2O (3:1 to 10:1).
Temperature/time: 70–100 °C, 2–16 h.
Notes: Protect the 6-amino group if nucleophilic side reactions occur; monitor for dehalogenation.
Sonogashira coupling (to 8-alkynyl adenines)
Catalyst/co-catalyst: PdCl2(PPh3)2 (1–2 mol%), CuI (5–10 mol%).
Base: Et3N or DIPEA (2–3 equiv).
Solvent: DMF or MeCN.
Temperature/time: 25–70 °C, 2–12 h.
Notes: Degas solvents; avoid excessive heating to limit side reactions.
Silylation: HMDS with catalytic TMSCl or BSA, reflux to form silylated base.
Glycosyl donor: Peracetylated ribose with TMSOTf or SnCl4 activation.
Solvent: MeCN or DCM (anhydrous).
Temperature/time: 0–25 °C, 1–6 h (activation), then warm if necessary.
Yields vary with substrate/ligand and protection strategy; optimize on small scale before scale-up.
Safety and Handling
Authoritative safety information is provided in the product SDS. The following is general guidance for adenine derivatives and aryl bromides.
GHS classification and pictograms: Not specified for this item; refer to SDS.
Signal word / H-statements: Not specified for this item; refer to SDS.
General hazards (literature/analog-based)
May cause irritation to eyes, skin, and respiratory tract as a fine organic powder. Avoid dust generation and inhalation.
Non-volatile; thermal decomposition at elevated temperature may release HBr, nitrogenous species, and brominated organics.
Recommended PPE and engineering controls
Wear lab coat, safety glasses, and appropriate chemical-resistant gloves (e.g., nitrile). Handle powders in a fume hood or with local exhaust to minimize dust exposure.
Use antistatic measures when weighing dry powders; keep containers closed when not in use.
Incompatibilities and precautions (general)
Strong bases/acids can change solubility and protonation state; handle deliberately if preparing solutions.
Avoid strong nucleophiles or reducing agents unless intended for reaction; C8–Br is reactive under cross-coupling or SNAr conditions.
Moisture sensitivity: not strongly hygroscopic, but store tightly sealed to prevent caking and contamination.
First aid overview (general)
Inhalation: Move to fresh air; seek medical advice if symptoms persist.
Skin/eye contact: Rinse with water for several minutes; remove contaminated clothing; seek medical attention if irritation continues.
Ingestion: Rinse mouth; do not induce vomiting; obtain medical attention.
Storage and shipping (from Product Data)
Storage: Store at 2–8 °C.
Shipping: Shipped on wet ice.
Solvent Selection
Application-driven solvent choices for 8-bromoadenine (general guidance):
Polarity and miscibility
The compound is polar/heteroatom-rich but aromatic; it dissolves best in strong hydrogen-bonding or highly polar aprotic media.
Favor DMSO, DMF, DMAc, NMP, or formamide for stock solutions or reactions.
Aqueous solubility is limited at neutral pH; solubility improves in mildly basic buffers (e.g., Tris, carbonate) or with co-solvent (5–30% DMSO).
Selection by use case
Cross-coupling (Suzuki/Sonogashira): DMF, DMAc, NMP, or dioxane/H2O mixtures with base (K2CO3, Cs2CO3). Add water to aid base solvation when appropriate.
Nucleophilic substitutions at C8: Polar aprotic solvents (DMSO, DMF) facilitate SNAr with amines/thiolates at elevated temperature.
Glycosylation to nucleosides: Vorbrüggen-type conditions typically employ acetonitrile or dichloromethane with silylated base; DMF may be used for alternative protocols.
Biochemical assays: Prepare concentrated DMSO stocks (e.g., 10–100 mM) and dilute into buffered media; filter if needed.
Practical tips
Warm gently (40–60 °C) to effect dissolution; avoid prolonged high-temperature heating that may promote decomposition.
Adjust pH to 8–9 for aqueous work to enhance solubility; avoid strong base unless required by the protocol.
If precipitation occurs upon dilution from DMSO, increase co-solvent fraction or add surfactant-compatible buffer depending on assay constraints.
Alternatives to consider
For greener profiles, consider 2-MeTHF or cyclopentyl methyl ether for coupling workups; for dissolution, PEG-400/water or ethanol/water co-solvent systems may suffice when pH-adjusted.
Storage and Reconstitution
Item-specific storage and shipping (from Product Data)
Storage conditions: Store at 2–8 °C.
Shipped in: Wet ice.
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
General reconstitution guidance (research use)
Solubility strategy: Start with anhydrous DMSO or DMF to prepare concentrated stocks (e.g., 10–100 mM). If aqueous solutions are required, dilute the organic stock slowly into buffered water with vigorous mixing.
pH assistance: Mildly basic buffers (pH 8–9) can improve aqueous solubility; avoid strong base unless required by the protocol.
Gentle warming (≤50–60 °C) and brief sonication can aid dissolution; do not overheat to prevent decomposition.
Storage of solutions
DMSO stocks: Store tightly capped under inert atmosphere or desiccation at 2–8 °C or freezer. Use amber vials to minimize light exposure.
Aqueous solutions: Prepare fresh when possible. For short-term storage (hours to a day), keep at 2–8 °C. Discard if precipitation or discoloration occurs.
Freeze–thaw: Minimize cycles by aliquoting. Thaw at room temperature and mix thoroughly before use.
Container and handling
Keep container tightly closed, protected from moisture and ambient humidity.
Record opening date and track solution age for reproducibility.
Always consult the lot-specific CoA/Spec Sheet and SDS for definitive handling, stability, and safety information.
Structure and Identity
Brief description: 8-Bromoadenine is a halogenated purine base derived from adenine with a bromine substituent at the C8 position of the fused imidazo[4,5-d]pyrimidine ring system.
Item-specific identifiers (from Product Data)
SKU: B353415
Product Name: 8-Bromoadenine
CAS: 6974-78-3
InChIKey: 93595 (as provided)
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
Literature/general identifiers and composition (for reference; not item-specific)
Molecular formula (literature): C5H4BrN5
Molecular weight (literature): ~214.02 g/mol
Preferred IUPAC name (literature): 8-bromoadenin-9(8H)-one is not correct; common name: 8-bromoadenine (substituted adenine at C8)
Functional groups: Exocyclic primary amine at C6 (–NH2), multiple ring nitrogens (sp2), and an aryl–bromide at C8.
Electrophilic handle: C8–Br enables cross-coupling and substitution chemistry on the purine ring.
Tautomerism: Purine ring tautomers exist; N9 is typically the glycosylation site in nucleoside synthesis.
2D description: A bicyclic aromatic system bearing an –NH2 on the six-membered ring and a bromine substituent at the adjacent five-membered ring carbon (C8).
Synthetic Utility
Key reactivity elements
Electrophilic C8–Br enables diverse bond formations on the adenine core via Pd- or Cu-catalyzed cross-coupling and via SNAr with heteroatom nucleophiles.
The exocyclic 6-amino group can be transiently protected (e.g., acyl, silyl, carbamate) to control chemoselectivity and regioselectivity in subsequent transformations.
Representative transformations (literature)
C–C coupling: Suzuki–Miyaura to install aryl/heteroaryl groups; Sonogashira to introduce alkynes; Negishi/Kumada variants for organozinc/magnesium nucleophiles (with appropriate protection and conditions).
C–N/O/S formation: Buchwald–Hartwig amination with anilines/alkylamines; Ullmann-type couplings to phenoxides/thiolates; direct SNAr under basic, heated conditions to give 8-amino/alkoxy/thio derivatives.
Directed lithiation is generally unsuitable at C8 due to the leaving group; metal–halogen exchange (e.g., with iPrMgCl·LiCl) enables further elaboration under carefully controlled, low-temperature conditions.
Nucleoside assembly
Vorbrüggen glycosylation of the N9 site following silylation (e.g., HMDS/TMSCl or BSA) affords 8-bromoadenosines. Subsequent C8 diversification on the nucleoside expands chemical space relevant to nucleotide chemistry.
Retrosynthetic value
8-Bromoadenine functions as a convergent node: prepare the adenine core early, then diversify late at C8 to access libraries with minimal protecting-group manipulations.
Practical considerations
Control moisture and air in Pd-catalyzed steps; screen ligand/base/solvent to suppress dehalogenation.
Analyze regioisomers after nucleoside formation (N7 vs N9) and optimize silylation/activation to favor N9.
Target Specificity
Not applicable. This product is a small-molecule research chemical (a halogenated purine), not a biological targeting reagent such as an antibody or affinity probe with defined antigen specificity.
Item-specific target/epitope/clone/isotype data: Not specified for this item; refer to CoA/Spec Sheet if an affinity conjugate is ordered separately.
Wir verwenden Cookies, um die ordnungsgemäße Funktion der Website sicherzustellen und, soweit zulässig, Ihr Nutzererlebnis zu verbessern. Sie können Ihre Einstellungen jederzeit unter „Einstellungen“ verwalten. Weitere Informationen finden Sie in unserer Cookie-Richtlinie.
Dürfen wir Sie über Rabattaktionen informieren?
Später erinnern
Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.